Table 3 Factors associated with HCC in patients with NAFLD.

From: Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma

Variable

Univariate analyses

Multivariate analyses

Odds ratio

p value

Odds ratio

p value

Age (per 1 year)

1.17 (1.09–1.25)

<0.001

1.16 (1.07–1.25)

<0.001

Gender, male

1.25 (0.51–3.00)

0.62

  

BMI (per 1 kg/m2)

0.99 (0.9–1.09)

0.91

  

Fibrosis stage (per 1 stage)

3.48 (2.05–5.91)

<0.001

2.87 (1.50–5.51)

0.002

AC5:0 (per 0.01 μmol/L)

0.89 (0.81–1.00)

0.03

  

AC18:1 (per 0.1 μmol/L)

1.19 (0.96–1.47)

0.1

  

(AC16:0 + AC18:1)/AC2:0 (per 0.01)

1.12 (1.00–1.27)

0.05

1.25 (1.05–1.48)

0.01

Back to article page